We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens

By LabMedica International staff writers
Posted on 20 Feb 2023
Print article
Image: The global microbiology diagnostic devices and equipment market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)
Image: The global microbiology diagnostic devices and equipment market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)

The global microbiology diagnostic devices and equipment market is expected to register a compound annual growth rate (CAGR) of 10.7% from USD 3.42 billion in 2021 to USD 5.69 billion in 2026 and grow further at a CAGR of 8.6% from 2026 to reach USD 8.56 billion in 2031. The market growth has been driven by increased healthcare expenditure, growth in the emerging markets, rapid technological advances, fast-paced increase in the aging population and the emergence of novel pathogenic infestations. However, regulatory challenges, political uncertainties, reduction in free trade and low healthcare reimbursements have negatively impacted market growth. Going forward, a rise in funding, growth in the aging population, enhanced healthcare access, and increase in various bacterial and viral epidemics will drive the growth of the global microbiology diagnostic devices and equipment market. However, the market growth could be hindered by a lack of skilled/trained microbiologists and insufficient and outdated health systems.

These are the latest findings of ResearchAndMarkets.com (Dublin, Ireland), a leading source for international market research reports and market data.

Based on type, the reagents and consumables market segment dominated the microbiology diagnostic devices and equipment market with the largest share of 80.6% in 2021 and is expected to register the fastest CAGR of 11.7% during the 2021-2026 forecast period. Based on type, the bacterial colony counters segment dominated the laboratory instruments market with the largest share of 24.8% in 2021 and is expected to register the fastest CAGR of 6.2% during the forecast period. Based on type, the microscopes segment dominated the microbiology analyzers market with the largest share of 56.1% in 2021 and is expected to register the fastest CAGR of 8.2% during the forecast period.

Based on type, the general reagents segment dominated the reagents and consumables market with the largest share of 60.5% in 2021. However, going forward, the pathogen-specific kits segment is expected to register the fastest CAGR of 14.6% during the forecast period. By end-user, the diagnostic laboratories segment dominated the microbiology diagnostic devices and equipment market with the largest share of 56.8% in 2021. However, going forward, the other end-users segment is expected to register the fastest CAGR of 10.9% during the forecast period.

Geographically, North America dominated the global microbiology diagnostic devices and equipment market with the largest share of 34.5% in 2021, followed by Asia Pacific and other regions. However, going forward, the microbiology diagnostic devices and equipment market in Africa and South America is expected to register the fastest CAGRs of 14.5% and 14.3%, respectively during the forecast period, followed by Eastern Europe and Middle East with CAGRs of 13.3% and 12.9%, respectively.

Related Links:
ResearchAndMarkets.com

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.